Literature DB >> 1957172

Hypotensive activity of fibroblast growth factor.

P Cuevas1, F Carceller, S Ortega, M Zazo, I Nieto, G Giménez-Gallego.   

Abstract

Acidic and basic fibroblast growth factors (FGFs) are members of a family of proteins that are broad-spectrum mitogens, have diverse hormone-like activities, and function in tumorigenesis. FGF's ability to raise the concentration of intracellular calcium ion suggests that FGF could induce the synthesis of endothelium-derived relaxing factor (EDRF) and consequently vasodilation. Systemic administration of FGF decreased arterial blood pressure. This effect was mediated by EDRF and by adenosine triphosphate-sensitive potassium ion channels. The hypotensive effect of FGF was segregated from its mitogenic activity by protein engineering. These results extend the range of FGF autocrine activities and potential therapeutic applications, emphasize the role of endothelium as an arterial blood pressure--regulating organ, and provide insight on the structural basis of FGF functions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1957172     DOI: 10.1126/science.1957172

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  42 in total

1.  Therapeutic Angiogenesis for Coronary Artery Disease.

Authors:  Tanveer A. Khan; Frank W. Sellke; Roger J. Laham
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-02

2.  An empirical phase diagram approach to investigate conformational stability of "second-generation" functional mutants of acidic fibroblast growth factor-1.

Authors:  Mohammad A Alsenaidy; Tingting Wang; Jae Hyun Kim; Sangeeta B Joshi; Jihun Lee; Michael Blaber; David B Volkin; C Russell Middaugh
Journal:  Protein Sci       Date:  2012-02-06       Impact factor: 6.725

3.  Fibroblast growth factor-2-induced cardioprotection against myocardial infarction occurs via the interplay between nitric oxide, protein kinase signaling, and ATP-sensitive potassium channels.

Authors:  Janet R Manning; Gregory Carpenter; Darius R Porter; Stacey L House; Daniel A Pietras; Thomas Doetschman; Jo el J Schultz
Journal:  Growth Factors       Date:  2012-02-06       Impact factor: 2.511

4.  Growth factor receptors as regulators of hematopoiesis.

Authors:  Michael A Weinreich; Ingrid Lintmaer; Linlin Wang; H Denny Liggitt; Michael A Harkey; C Anthony Blau
Journal:  Blood       Date:  2006-08-10       Impact factor: 22.113

Review 5.  Role of fibroblast growth factors in elicitation of cell responses.

Authors:  C Laestander; W Engström
Journal:  Cell Prolif       Date:  2013-12-20       Impact factor: 6.831

Review 6.  Neuroprotection in experimental stroke with targeted neurotrophins.

Authors:  Dafang Wu
Journal:  NeuroRx       Date:  2005-01

Review 7.  Neuroprotection for ischemic stroke: two decades of success and failure.

Authors:  Yu Dennis Cheng; Lama Al-Khoury; Justin A Zivin
Journal:  NeuroRx       Date:  2004-01

Review 8.  Mechanisms of restenosis.

Authors:  W Casscells; D Engler; J T Willerson
Journal:  Tex Heart Inst J       Date:  1994

9.  Basic fibroblast growth factor is cardioprotective in ischemia-reperfusion injury.

Authors:  R R Padua; R Sethi; N S Dhalla; E Kardami
Journal:  Mol Cell Biochem       Date:  1995-02-23       Impact factor: 3.396

Review 10.  Therapeutic angiogenesis in diabetes and hypercholesterolemia: influence of oxidative stress.

Authors:  Munir Boodhwani; Frank W Sellke
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.